nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—CYP2B6—Thiotepa—sarcoma	0.312	0.514	CbGbCtD
Pethidine—CYP3A4—Thiotepa—sarcoma	0.0958	0.158	CbGbCtD
Pethidine—CYP2B6—Doxorubicin—sarcoma	0.0577	0.0951	CbGbCtD
Pethidine—CYP3A4—Mitoxantrone—sarcoma	0.0412	0.0679	CbGbCtD
Pethidine—CYP3A4—Vincristine—sarcoma	0.0284	0.0467	CbGbCtD
Pethidine—CYP2D6—Doxorubicin—sarcoma	0.0279	0.0459	CbGbCtD
Pethidine—CYP3A4—Etoposide—sarcoma	0.026	0.0428	CbGbCtD
Pethidine—Cardiovascular insufficiency—Thiotepa—sarcoma	0.0237	0.0904	CcSEcCtD
Pethidine—CYP3A4—Doxorubicin—sarcoma	0.0177	0.0292	CbGbCtD
Pethidine—Neurotoxicity—Vincristine—sarcoma	0.00734	0.028	CcSEcCtD
Pethidine—Respiratory arrest—Thiotepa—sarcoma	0.0073	0.0278	CcSEcCtD
Pethidine—Neurotoxicity—Etoposide—sarcoma	0.00595	0.0227	CcSEcCtD
Pethidine—Induration—Etoposide—sarcoma	0.00516	0.0197	CcSEcCtD
Pethidine—Myoclonus—Vincristine—sarcoma	0.00473	0.018	CcSEcCtD
Pethidine—Paralysis—Vincristine—sarcoma	0.0041	0.0156	CcSEcCtD
Pethidine—Injection site pain—Thiotepa—sarcoma	0.00393	0.015	CcSEcCtD
Pethidine—Delirium—Thiotepa—sarcoma	0.00373	0.0142	CcSEcCtD
Pethidine—Anuria—Epirubicin—sarcoma	0.0037	0.0141	CcSEcCtD
Pethidine—Anuria—Doxorubicin—sarcoma	0.00342	0.013	CcSEcCtD
Pethidine—Neurotoxicity—Epirubicin—sarcoma	0.00333	0.0127	CcSEcCtD
Pethidine—Neurotoxicity—Doxorubicin—sarcoma	0.00308	0.0118	CcSEcCtD
Pethidine—Phlebitis—Dactinomycin—sarcoma	0.00268	0.0102	CcSEcCtD
Pethidine—Coma—Vincristine—sarcoma	0.0026	0.00991	CcSEcCtD
Pethidine—Phlebitis—Mitoxantrone—sarcoma	0.00234	0.0089	CcSEcCtD
Pethidine—Urinary retention—Thiotepa—sarcoma	0.00222	0.00844	CcSEcCtD
Pethidine—Cardiac arrest—Thiotepa—sarcoma	0.00222	0.00844	CcSEcCtD
Pethidine—Urinary retention—Vincristine—sarcoma	0.00196	0.00749	CcSEcCtD
Pethidine—Cardiac arrest—Vincristine—sarcoma	0.00196	0.00749	CcSEcCtD
Pethidine—Phlebitis—Etoposide—sarcoma	0.00194	0.0074	CcSEcCtD
Pethidine—Paralysis—Epirubicin—sarcoma	0.00186	0.00709	CcSEcCtD
Pethidine—Paralysis—Doxorubicin—sarcoma	0.00172	0.00656	CcSEcCtD
Pethidine—Hallucination—Thiotepa—sarcoma	0.0016	0.00611	CcSEcCtD
Pethidine—Cardiac arrest—Etoposide—sarcoma	0.00159	0.00606	CcSEcCtD
Pethidine—Injection site pain—Epirubicin—sarcoma	0.00158	0.00603	CcSEcCtD
Pethidine—Drowsiness—Mitoxantrone—sarcoma	0.00155	0.00591	CcSEcCtD
Pethidine—Sweating—Vincristine—sarcoma	0.00153	0.00582	CcSEcCtD
Pethidine—Delirium—Epirubicin—sarcoma	0.0015	0.00573	CcSEcCtD
Pethidine—Sweating—Mitoxantrone—sarcoma	0.00149	0.00566	CcSEcCtD
Pethidine—Flushing—Dactinomycin—sarcoma	0.00148	0.00566	CcSEcCtD
Pethidine—Vasodilation procedure—Epirubicin—sarcoma	0.00147	0.00561	CcSEcCtD
Pethidine—Vasodilation—Epirubicin—sarcoma	0.00147	0.00561	CcSEcCtD
Pethidine—Injection site pain—Doxorubicin—sarcoma	0.00146	0.00558	CcSEcCtD
Pethidine—Hallucination—Vincristine—sarcoma	0.00142	0.00542	CcSEcCtD
Pethidine—Bradycardia—Mitoxantrone—sarcoma	0.00142	0.0054	CcSEcCtD
Pethidine—Erythema—Thiotepa—sarcoma	0.0014	0.00535	CcSEcCtD
Pethidine—Erythema—Dactinomycin—sarcoma	0.00139	0.00531	CcSEcCtD
Pethidine—Delirium—Doxorubicin—sarcoma	0.00139	0.0053	CcSEcCtD
Pethidine—Dyskinesia—Epirubicin—sarcoma	0.00138	0.00524	CcSEcCtD
Pethidine—Vasodilation procedure—Doxorubicin—sarcoma	0.00136	0.00519	CcSEcCtD
Pethidine—Vasodilation—Doxorubicin—sarcoma	0.00136	0.00519	CcSEcCtD
Pethidine—Coordination abnormal—Epirubicin—sarcoma	0.00132	0.00502	CcSEcCtD
Pethidine—Agitation—Thiotepa—sarcoma	0.00129	0.00491	CcSEcCtD
Pethidine—Dyskinesia—Doxorubicin—sarcoma	0.00127	0.00485	CcSEcCtD
Pethidine—Coordination abnormal—Doxorubicin—sarcoma	0.00122	0.00464	CcSEcCtD
Pethidine—Convulsion—Thiotepa—sarcoma	0.00122	0.00463	CcSEcCtD
Pethidine—Erythema—Mitoxantrone—sarcoma	0.00121	0.00462	CcSEcCtD
Pethidine—Hypertension—Thiotepa—sarcoma	0.00121	0.00462	CcSEcCtD
Pethidine—Anxiety—Thiotepa—sarcoma	0.00119	0.00454	CcSEcCtD
Pethidine—Coma—Epirubicin—sarcoma	0.00118	0.0045	CcSEcCtD
Pethidine—Confusional state—Thiotepa—sarcoma	0.00115	0.0044	CcSEcCtD
Pethidine—Agitation—Vincristine—sarcoma	0.00114	0.00436	CcSEcCtD
Pethidine—Oedema—Dactinomycin—sarcoma	0.00114	0.00433	CcSEcCtD
Pethidine—Vertigo—Vincristine—sarcoma	0.00112	0.00426	CcSEcCtD
Pethidine—Tachycardia—Thiotepa—sarcoma	0.00112	0.00426	CcSEcCtD
Pethidine—Coma—Doxorubicin—sarcoma	0.00109	0.00416	CcSEcCtD
Pethidine—Anorexia—Thiotepa—sarcoma	0.00109	0.00416	CcSEcCtD
Pethidine—Phlebitis—Epirubicin—sarcoma	0.00109	0.00415	CcSEcCtD
Pethidine—Anorexia—Dactinomycin—sarcoma	0.00108	0.00413	CcSEcCtD
Pethidine—Convulsion—Vincristine—sarcoma	0.00108	0.00411	CcSEcCtD
Pethidine—Flushing—Etoposide—sarcoma	0.00107	0.0041	CcSEcCtD
Pethidine—Hypertension—Vincristine—sarcoma	0.00107	0.00409	CcSEcCtD
Pethidine—Convulsion—Mitoxantrone—sarcoma	0.00105	0.004	CcSEcCtD
Pethidine—Hypertension—Mitoxantrone—sarcoma	0.00105	0.00399	CcSEcCtD
Pethidine—Anxiety—Mitoxantrone—sarcoma	0.00103	0.00392	CcSEcCtD
Pethidine—Somnolence—Thiotepa—sarcoma	0.00102	0.00388	CcSEcCtD
Pethidine—Oedema—Vincristine—sarcoma	0.00102	0.00387	CcSEcCtD
Pethidine—Anaphylactic shock—Vincristine—sarcoma	0.00102	0.00387	CcSEcCtD
Pethidine—Phlebitis—Doxorubicin—sarcoma	0.00101	0.00384	CcSEcCtD
Pethidine—Confusional state—Mitoxantrone—sarcoma	0.000997	0.0038	CcSEcCtD
Pethidine—Decreased appetite—Thiotepa—sarcoma	0.000995	0.00379	CcSEcCtD
Pethidine—Anaphylactic shock—Mitoxantrone—sarcoma	0.000989	0.00377	CcSEcCtD
Pethidine—Oedema—Mitoxantrone—sarcoma	0.000989	0.00377	CcSEcCtD
Pethidine—Decreased appetite—Dactinomycin—sarcoma	0.000988	0.00377	CcSEcCtD
Pethidine—Hyperhidrosis—Vincristine—sarcoma	0.000982	0.00374	CcSEcCtD
Pethidine—Constipation—Thiotepa—sarcoma	0.000979	0.00373	CcSEcCtD
Pethidine—Shock—Mitoxantrone—sarcoma	0.000973	0.00371	CcSEcCtD
Pethidine—Muscle spasms—Etoposide—sarcoma	0.000969	0.00369	CcSEcCtD
Pethidine—Anorexia—Vincristine—sarcoma	0.000968	0.00369	CcSEcCtD
Pethidine—Tachycardia—Mitoxantrone—sarcoma	0.000965	0.00368	CcSEcCtD
Pethidine—Hyperhidrosis—Mitoxantrone—sarcoma	0.000956	0.00364	CcSEcCtD
Pethidine—Hypotension—Vincristine—sarcoma	0.000949	0.00362	CcSEcCtD
Pethidine—Feeling abnormal—Thiotepa—sarcoma	0.000944	0.0036	CcSEcCtD
Pethidine—Anorexia—Mitoxantrone—sarcoma	0.000943	0.00359	CcSEcCtD
Pethidine—Feeling abnormal—Dactinomycin—sarcoma	0.000937	0.00357	CcSEcCtD
Pethidine—Hypotension—Mitoxantrone—sarcoma	0.000924	0.00352	CcSEcCtD
Pethidine—Affect lability—Epirubicin—sarcoma	0.000923	0.00352	CcSEcCtD
Pethidine—Insomnia—Vincristine—sarcoma	0.000918	0.0035	CcSEcCtD
Pethidine—Urticaria—Thiotepa—sarcoma	0.00091	0.00347	CcSEcCtD
Pethidine—Vertigo—Etoposide—sarcoma	0.000905	0.00345	CcSEcCtD
Pethidine—Cardiac arrest—Epirubicin—sarcoma	0.000892	0.0034	CcSEcCtD
Pethidine—Mood swings—Epirubicin—sarcoma	0.000889	0.00339	CcSEcCtD
Pethidine—Loss of consciousness—Etoposide—sarcoma	0.000886	0.00338	CcSEcCtD
Pethidine—Decreased appetite—Vincristine—sarcoma	0.000883	0.00336	CcSEcCtD
Pethidine—Somnolence—Mitoxantrone—sarcoma	0.000879	0.00335	CcSEcCtD
Pethidine—Convulsion—Etoposide—sarcoma	0.000873	0.00333	CcSEcCtD
Pethidine—Hypertension—Etoposide—sarcoma	0.00087	0.00332	CcSEcCtD
Pethidine—Constipation—Vincristine—sarcoma	0.000868	0.00331	CcSEcCtD
Pethidine—Decreased appetite—Mitoxantrone—sarcoma	0.00086	0.00328	CcSEcCtD
Pethidine—Orthostatic hypotension—Epirubicin—sarcoma	0.000857	0.00327	CcSEcCtD
Pethidine—Affect lability—Doxorubicin—sarcoma	0.000854	0.00326	CcSEcCtD
Pethidine—Constipation—Mitoxantrone—sarcoma	0.000846	0.00322	CcSEcCtD
Pethidine—Hypersensitivity—Thiotepa—sarcoma	0.000844	0.00322	CcSEcCtD
Pethidine—Hypersensitivity—Dactinomycin—sarcoma	0.000837	0.00319	CcSEcCtD
Pethidine—Confusional state—Etoposide—sarcoma	0.000829	0.00316	CcSEcCtD
Pethidine—Cardiac arrest—Doxorubicin—sarcoma	0.000825	0.00315	CcSEcCtD
Pethidine—Anaphylactic shock—Etoposide—sarcoma	0.000823	0.00313	CcSEcCtD
Pethidine—Mood swings—Doxorubicin—sarcoma	0.000822	0.00313	CcSEcCtD
Pethidine—Asthenia—Thiotepa—sarcoma	0.000822	0.00313	CcSEcCtD
Pethidine—Asthenia—Dactinomycin—sarcoma	0.000815	0.00311	CcSEcCtD
Pethidine—Feeling abnormal—Mitoxantrone—sarcoma	0.000815	0.00311	CcSEcCtD
Pethidine—Pruritus—Thiotepa—sarcoma	0.00081	0.00309	CcSEcCtD
Pethidine—Tachycardia—Etoposide—sarcoma	0.000803	0.00306	CcSEcCtD
Pethidine—Hyperhidrosis—Etoposide—sarcoma	0.000795	0.00303	CcSEcCtD
Pethidine—Orthostatic hypotension—Doxorubicin—sarcoma	0.000793	0.00302	CcSEcCtD
Pethidine—Urticaria—Mitoxantrone—sarcoma	0.000786	0.00299	CcSEcCtD
Pethidine—Anorexia—Etoposide—sarcoma	0.000784	0.00299	CcSEcCtD
Pethidine—Hypotension—Etoposide—sarcoma	0.000769	0.00293	CcSEcCtD
Pethidine—Dizziness—Thiotepa—sarcoma	0.000757	0.00289	CcSEcCtD
Pethidine—Hypersensitivity—Vincristine—sarcoma	0.000748	0.00285	CcSEcCtD
Pethidine—Somnolence—Etoposide—sarcoma	0.000731	0.00279	CcSEcCtD
Pethidine—Hypersensitivity—Mitoxantrone—sarcoma	0.000729	0.00278	CcSEcCtD
Pethidine—Asthenia—Vincristine—sarcoma	0.000728	0.00278	CcSEcCtD
Pethidine—Vomiting—Thiotepa—sarcoma	0.000728	0.00277	CcSEcCtD
Pethidine—Drowsiness—Epirubicin—sarcoma	0.000723	0.00276	CcSEcCtD
Pethidine—Vomiting—Dactinomycin—sarcoma	0.000723	0.00275	CcSEcCtD
Pethidine—Rash—Thiotepa—sarcoma	0.000722	0.00275	CcSEcCtD
Pethidine—Dermatitis—Thiotepa—sarcoma	0.000721	0.00275	CcSEcCtD
Pethidine—Headache—Thiotepa—sarcoma	0.000717	0.00273	CcSEcCtD
Pethidine—Rash—Dactinomycin—sarcoma	0.000717	0.00273	CcSEcCtD
Pethidine—Decreased appetite—Etoposide—sarcoma	0.000715	0.00273	CcSEcCtD
Pethidine—Asthenia—Mitoxantrone—sarcoma	0.000709	0.0027	CcSEcCtD
Pethidine—Constipation—Etoposide—sarcoma	0.000703	0.00268	CcSEcCtD
Pethidine—Sweating—Epirubicin—sarcoma	0.000693	0.00264	CcSEcCtD
Pethidine—Nausea—Thiotepa—sarcoma	0.00068	0.00259	CcSEcCtD
Pethidine—Feeling abnormal—Etoposide—sarcoma	0.000678	0.00258	CcSEcCtD
Pethidine—Nausea—Dactinomycin—sarcoma	0.000675	0.00257	CcSEcCtD
Pethidine—Dizziness—Vincristine—sarcoma	0.000671	0.00256	CcSEcCtD
Pethidine—Drowsiness—Doxorubicin—sarcoma	0.000669	0.00255	CcSEcCtD
Pethidine—Bradycardia—Epirubicin—sarcoma	0.000661	0.00252	CcSEcCtD
Pethidine—Urticaria—Etoposide—sarcoma	0.000653	0.00249	CcSEcCtD
Pethidine—Vomiting—Vincristine—sarcoma	0.000646	0.00246	CcSEcCtD
Pethidine—Sweating—Doxorubicin—sarcoma	0.000641	0.00244	CcSEcCtD
Pethidine—Rash—Vincristine—sarcoma	0.00064	0.00244	CcSEcCtD
Pethidine—Dermatitis—Vincristine—sarcoma	0.00064	0.00244	CcSEcCtD
Pethidine—Headache—Vincristine—sarcoma	0.000636	0.00242	CcSEcCtD
Pethidine—Vomiting—Mitoxantrone—sarcoma	0.000629	0.0024	CcSEcCtD
Pethidine—Visual impairment—Epirubicin—sarcoma	0.000625	0.00238	CcSEcCtD
Pethidine—Rash—Mitoxantrone—sarcoma	0.000623	0.00238	CcSEcCtD
Pethidine—Dermatitis—Mitoxantrone—sarcoma	0.000623	0.00237	CcSEcCtD
Pethidine—Headache—Mitoxantrone—sarcoma	0.000619	0.00236	CcSEcCtD
Pethidine—Bradycardia—Doxorubicin—sarcoma	0.000611	0.00233	CcSEcCtD
Pethidine—Hypersensitivity—Etoposide—sarcoma	0.000606	0.00231	CcSEcCtD
Pethidine—Nausea—Vincristine—sarcoma	0.000603	0.0023	CcSEcCtD
Pethidine—Flushing—Epirubicin—sarcoma	0.000602	0.0023	CcSEcCtD
Pethidine—Asthenia—Etoposide—sarcoma	0.00059	0.00225	CcSEcCtD
Pethidine—Nausea—Mitoxantrone—sarcoma	0.000587	0.00224	CcSEcCtD
Pethidine—Pruritus—Etoposide—sarcoma	0.000582	0.00222	CcSEcCtD
Pethidine—Visual impairment—Doxorubicin—sarcoma	0.000579	0.00221	CcSEcCtD
Pethidine—Erythema—Epirubicin—sarcoma	0.000565	0.00215	CcSEcCtD
Pethidine—Flushing—Doxorubicin—sarcoma	0.000557	0.00212	CcSEcCtD
Pethidine—Dizziness—Etoposide—sarcoma	0.000544	0.00207	CcSEcCtD
Pethidine—Muscle spasms—Epirubicin—sarcoma	0.000543	0.00207	CcSEcCtD
Pethidine—Vomiting—Etoposide—sarcoma	0.000523	0.00199	CcSEcCtD
Pethidine—Erythema—Doxorubicin—sarcoma	0.000523	0.00199	CcSEcCtD
Pethidine—Agitation—Epirubicin—sarcoma	0.000519	0.00198	CcSEcCtD
Pethidine—Rash—Etoposide—sarcoma	0.000519	0.00198	CcSEcCtD
Pethidine—Dermatitis—Etoposide—sarcoma	0.000518	0.00197	CcSEcCtD
Pethidine—Headache—Etoposide—sarcoma	0.000515	0.00196	CcSEcCtD
Pethidine—Vertigo—Epirubicin—sarcoma	0.000508	0.00193	CcSEcCtD
Pethidine—Syncope—Epirubicin—sarcoma	0.000507	0.00193	CcSEcCtD
Pethidine—Muscle spasms—Doxorubicin—sarcoma	0.000503	0.00192	CcSEcCtD
Pethidine—Palpitations—Epirubicin—sarcoma	0.000499	0.0019	CcSEcCtD
Pethidine—Loss of consciousness—Epirubicin—sarcoma	0.000497	0.00189	CcSEcCtD
Pethidine—Convulsion—Epirubicin—sarcoma	0.000489	0.00187	CcSEcCtD
Pethidine—Nausea—Etoposide—sarcoma	0.000489	0.00186	CcSEcCtD
Pethidine—Hypertension—Epirubicin—sarcoma	0.000488	0.00186	CcSEcCtD
Pethidine—Agitation—Doxorubicin—sarcoma	0.00048	0.00183	CcSEcCtD
Pethidine—Anxiety—Epirubicin—sarcoma	0.000479	0.00183	CcSEcCtD
Pethidine—Dry mouth—Epirubicin—sarcoma	0.00047	0.00179	CcSEcCtD
Pethidine—Vertigo—Doxorubicin—sarcoma	0.00047	0.00179	CcSEcCtD
Pethidine—Syncope—Doxorubicin—sarcoma	0.000469	0.00179	CcSEcCtD
Pethidine—Confusional state—Epirubicin—sarcoma	0.000465	0.00177	CcSEcCtD
Pethidine—Palpitations—Doxorubicin—sarcoma	0.000462	0.00176	CcSEcCtD
Pethidine—Anaphylactic shock—Epirubicin—sarcoma	0.000461	0.00176	CcSEcCtD
Pethidine—Oedema—Epirubicin—sarcoma	0.000461	0.00176	CcSEcCtD
Pethidine—Loss of consciousness—Doxorubicin—sarcoma	0.000459	0.00175	CcSEcCtD
Pethidine—Shock—Epirubicin—sarcoma	0.000454	0.00173	CcSEcCtD
Pethidine—Convulsion—Doxorubicin—sarcoma	0.000453	0.00173	CcSEcCtD
Pethidine—Hypertension—Doxorubicin—sarcoma	0.000451	0.00172	CcSEcCtD
Pethidine—Tachycardia—Epirubicin—sarcoma	0.00045	0.00171	CcSEcCtD
Pethidine—OPRK1—Peptide ligand-binding receptors—CXCR4—sarcoma	0.000446	0.0034	CbGpPWpGaD
Pethidine—Hyperhidrosis—Epirubicin—sarcoma	0.000446	0.0017	CcSEcCtD
Pethidine—Anxiety—Doxorubicin—sarcoma	0.000443	0.00169	CcSEcCtD
Pethidine—Anorexia—Epirubicin—sarcoma	0.000439	0.00167	CcSEcCtD
Pethidine—Dry mouth—Doxorubicin—sarcoma	0.000435	0.00166	CcSEcCtD
Pethidine—GRIN1—Axon guidance—PTPRC—sarcoma	0.000432	0.0033	CbGpPWpGaD
Pethidine—Hypotension—Epirubicin—sarcoma	0.000431	0.00164	CcSEcCtD
Pethidine—Confusional state—Doxorubicin—sarcoma	0.00043	0.00164	CcSEcCtD
Pethidine—Anaphylactic shock—Doxorubicin—sarcoma	0.000427	0.00163	CcSEcCtD
Pethidine—Oedema—Doxorubicin—sarcoma	0.000427	0.00163	CcSEcCtD
Pethidine—GRIN1—Developmental Biology—MYOD1—sarcoma	0.000427	0.00325	CbGpPWpGaD
Pethidine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.000426	0.00325	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—PLCG1—sarcoma	0.000423	0.00323	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—PTPRC—sarcoma	0.000421	0.00321	CbGpPWpGaD
Pethidine—Shock—Doxorubicin—sarcoma	0.00042	0.0016	CcSEcCtD
Pethidine—Insomnia—Epirubicin—sarcoma	0.000417	0.00159	CcSEcCtD
Pethidine—GRIN1—BDNF signaling pathway—CREB1—sarcoma	0.000416	0.00318	CbGpPWpGaD
Pethidine—Tachycardia—Doxorubicin—sarcoma	0.000416	0.00159	CcSEcCtD
Pethidine—GRIN2B—Developmental Biology—MYOD1—sarcoma	0.000416	0.00317	CbGpPWpGaD
Pethidine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.000415	0.00317	CbGpPWpGaD
Pethidine—Hyperhidrosis—Doxorubicin—sarcoma	0.000412	0.00157	CcSEcCtD
Pethidine—GRIN2B—Axon guidance—PLCG1—sarcoma	0.000412	0.00315	CbGpPWpGaD
Pethidine—Somnolence—Epirubicin—sarcoma	0.00041	0.00156	CcSEcCtD
Pethidine—Anorexia—Doxorubicin—sarcoma	0.000407	0.00155	CcSEcCtD
Pethidine—GRIN2B—BDNF signaling pathway—CREB1—sarcoma	0.000406	0.0031	CbGpPWpGaD
Pethidine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000404	0.00308	CbGpPWpGaD
Pethidine—Decreased appetite—Epirubicin—sarcoma	0.000401	0.00153	CcSEcCtD
Pethidine—OPRM1—Opioid Signalling—CREB1—sarcoma	0.000399	0.00305	CbGpPWpGaD
Pethidine—Hypotension—Doxorubicin—sarcoma	0.000399	0.00152	CcSEcCtD
Pethidine—GRIN2C—Transmission across Chemical Synapses—MDM2—sarcoma	0.000398	0.00303	CbGpPWpGaD
Pethidine—Constipation—Epirubicin—sarcoma	0.000394	0.0015	CcSEcCtD
Pethidine—GRIN1—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000391	0.00298	CbGpPWpGaD
Pethidine—Insomnia—Doxorubicin—sarcoma	0.000386	0.00147	CcSEcCtD
Pethidine—Feeling abnormal—Epirubicin—sarcoma	0.00038	0.00145	CcSEcCtD
Pethidine—Somnolence—Doxorubicin—sarcoma	0.000379	0.00145	CcSEcCtD
Pethidine—GRIN1—EPH-Ephrin signaling—SRC—sarcoma	0.000378	0.00288	CbGpPWpGaD
Pethidine—OPRM1—Peptide ligand-binding receptors—CXCR4—sarcoma	0.000377	0.00288	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—CXCR4—sarcoma	0.000376	0.00287	CbGpPWpGaD
Pethidine—Decreased appetite—Doxorubicin—sarcoma	0.000371	0.00141	CcSEcCtD
Pethidine—GRIN2D—Transmission across Chemical Synapses—MDM2—sarcoma	0.00037	0.00282	CbGpPWpGaD
Pethidine—GRIN2C—Neuronal System—CREB1—sarcoma	0.000368	0.00281	CbGpPWpGaD
Pethidine—GRIN2B—EPH-Ephrin signaling—SRC—sarcoma	0.000368	0.00281	CbGpPWpGaD
Pethidine—GRIN1—EPH-Ephrin signaling—VEGFA—sarcoma	0.000368	0.00281	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—CREB1—sarcoma	0.000367	0.0028	CbGpPWpGaD
Pethidine—GRIN2A—Transmission across Chemical Synapses—CREB1—sarcoma	0.000367	0.0028	CbGpPWpGaD
Pethidine—GRIN2A—Alzheimers Disease—TP53—sarcoma	0.000366	0.00279	CbGpPWpGaD
Pethidine—Urticaria—Epirubicin—sarcoma	0.000366	0.0014	CcSEcCtD
Pethidine—Constipation—Doxorubicin—sarcoma	0.000365	0.00139	CcSEcCtD
Pethidine—GRIN1—Spinal Cord Injury—IL2—sarcoma	0.000361	0.00275	CbGpPWpGaD
Pethidine—GRIN2B—EPH-Ephrin signaling—VEGFA—sarcoma	0.000359	0.00274	CbGpPWpGaD
Pethidine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000352	0.00269	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—CCND1—sarcoma	0.000352	0.00268	CbGpPWpGaD
Pethidine—Feeling abnormal—Doxorubicin—sarcoma	0.000352	0.00134	CcSEcCtD
Pethidine—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.000349	0.00266	CbGpPWpGaD
Pethidine—ALB—FOXA2 and FOXA3 transcription factor networks—CREB1—sarcoma	0.000348	0.00266	CbGpPWpGaD
Pethidine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000343	0.00262	CbGpPWpGaD
Pethidine—GRIN2D—Neuronal System—CREB1—sarcoma	0.000342	0.00261	CbGpPWpGaD
Pethidine—Hypersensitivity—Epirubicin—sarcoma	0.00034	0.00129	CcSEcCtD
Pethidine—Urticaria—Doxorubicin—sarcoma	0.000339	0.00129	CcSEcCtD
Pethidine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000335	0.00255	CbGpPWpGaD
Pethidine—Asthenia—Epirubicin—sarcoma	0.000331	0.00126	CcSEcCtD
Pethidine—Pruritus—Epirubicin—sarcoma	0.000326	0.00124	CcSEcCtD
Pethidine—GRIN1—Transmission across Chemical Synapses—CREB1—sarcoma	0.00032	0.00244	CbGpPWpGaD
Pethidine—GRIN1—Alzheimers Disease—TP53—sarcoma	0.00032	0.00244	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—CXCR4—sarcoma	0.000318	0.00243	CbGpPWpGaD
Pethidine—Hypersensitivity—Doxorubicin—sarcoma	0.000314	0.0012	CcSEcCtD
Pethidine—GRIN2B—Transmission across Chemical Synapses—CREB1—sarcoma	0.000312	0.00238	CbGpPWpGaD
Pethidine—GRIN2B—Alzheimers Disease—TP53—sarcoma	0.000312	0.00238	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—PTPRC—sarcoma	0.000308	0.00235	CbGpPWpGaD
Pethidine—Asthenia—Doxorubicin—sarcoma	0.000306	0.00117	CcSEcCtD
Pethidine—Dizziness—Epirubicin—sarcoma	0.000305	0.00116	CcSEcCtD
Pethidine—GRIN2C—Neuronal System—MDM2—sarcoma	0.000305	0.00233	CbGpPWpGaD
Pethidine—GRIN2A—Transmission across Chemical Synapses—MDM2—sarcoma	0.000304	0.00232	CbGpPWpGaD
Pethidine—Pruritus—Doxorubicin—sarcoma	0.000302	0.00115	CcSEcCtD
Pethidine—GRIN1—Developmental Biology—PLCG1—sarcoma	0.000302	0.0023	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—PTPRC—sarcoma	0.000301	0.00229	CbGpPWpGaD
Pethidine—GRIN1—BDNF signaling pathway—JUN—sarcoma	0.000299	0.00228	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.000299	0.00228	CbGpPWpGaD
Pethidine—GRIN1—BDNF signaling pathway—CTNNB1—sarcoma	0.000297	0.00227	CbGpPWpGaD
Pethidine—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.000295	0.00225	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—PLCG1—sarcoma	0.000294	0.00224	CbGpPWpGaD
Pethidine—Vomiting—Epirubicin—sarcoma	0.000293	0.00112	CcSEcCtD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000293	0.00223	CbGpPWpGaD
Pethidine—GRIN2B—BDNF signaling pathway—JUN—sarcoma	0.000292	0.00223	CbGpPWpGaD
Pethidine—Rash—Epirubicin—sarcoma	0.000291	0.00111	CcSEcCtD
Pethidine—Dermatitis—Epirubicin—sarcoma	0.00029	0.00111	CcSEcCtD
Pethidine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.00029	0.00222	CbGpPWpGaD
Pethidine—GRIN2B—BDNF signaling pathway—CTNNB1—sarcoma	0.00029	0.00221	CbGpPWpGaD
Pethidine—Headache—Epirubicin—sarcoma	0.000289	0.0011	CcSEcCtD
Pethidine—GRIN2D—Neuronal System—MDM2—sarcoma	0.000283	0.00216	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—MYC—sarcoma	0.000282	0.00215	CbGpPWpGaD
Pethidine—Dizziness—Doxorubicin—sarcoma	0.000282	0.00108	CcSEcCtD
Pethidine—GRIN2A—Neuronal System—CREB1—sarcoma	0.000281	0.00215	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—JUN—sarcoma	0.000281	0.00214	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000279	0.00213	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—EGFR—sarcoma	0.000276	0.00211	CbGpPWpGaD
Pethidine—Nausea—Epirubicin—sarcoma	0.000274	0.00104	CcSEcCtD
Pethidine—Vomiting—Doxorubicin—sarcoma	0.000271	0.00103	CcSEcCtD
Pethidine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.00027	0.00206	CbGpPWpGaD
Pethidine—Rash—Doxorubicin—sarcoma	0.000269	0.00103	CcSEcCtD
Pethidine—Dermatitis—Doxorubicin—sarcoma	0.000269	0.00102	CcSEcCtD
Pethidine—GRIN1—BDNF signaling pathway—SRC—sarcoma	0.000269	0.00205	CbGpPWpGaD
Pethidine—Headache—Doxorubicin—sarcoma	0.000267	0.00102	CcSEcCtD
Pethidine—GRIN1—EPH-Ephrin signaling—HRAS—sarcoma	0.000266	0.00203	CbGpPWpGaD
Pethidine—GRIN1—Transmission across Chemical Synapses—MDM2—sarcoma	0.000265	0.00202	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—JUN—sarcoma	0.000264	0.00201	CbGpPWpGaD
Pethidine—GRIN2B—BDNF signaling pathway—SRC—sarcoma	0.000262	0.002	CbGpPWpGaD
Pethidine—GRIN2B—EPH-Ephrin signaling—HRAS—sarcoma	0.000259	0.00198	CbGpPWpGaD
Pethidine—GRIN2B—Transmission across Chemical Synapses—MDM2—sarcoma	0.000258	0.00197	CbGpPWpGaD
Pethidine—Nausea—Doxorubicin—sarcoma	0.000253	0.000966	CcSEcCtD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.000253	0.00193	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—KDR—sarcoma	0.000248	0.00189	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000245	0.00187	CbGpPWpGaD
Pethidine—GRIN1—Neuronal System—CREB1—sarcoma	0.000245	0.00187	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—KDR—sarcoma	0.000242	0.00185	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—CREB1—sarcoma	0.000239	0.00182	CbGpPWpGaD
Pethidine—GRIN2B—Neuronal System—CREB1—sarcoma	0.000239	0.00182	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—VEGFC—sarcoma	0.000237	0.00181	CbGpPWpGaD
Pethidine—GRIN2A—Neuronal System—MDM2—sarcoma	0.000233	0.00178	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—TP53—sarcoma	0.000232	0.00177	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—CXCR4—sarcoma	0.000228	0.00174	CbGpPWpGaD
Pethidine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000222	0.00169	CbGpPWpGaD
Pethidine—GRIN2C—Transmission across Chemical Synapses—HRAS—sarcoma	0.000218	0.00167	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—CREB1—sarcoma	0.000218	0.00166	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—FOXO1—sarcoma	0.000214	0.00163	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—CREB1—sarcoma	0.000212	0.00162	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—JUN—sarcoma	0.000211	0.00161	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000209	0.00159	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—FOXO1—sarcoma	0.000209	0.00159	CbGpPWpGaD
Pethidine—GRIN1—Neuronal System—MDM2—sarcoma	0.000203	0.00155	CbGpPWpGaD
Pethidine—GRIN2D—Transmission across Chemical Synapses—HRAS—sarcoma	0.000203	0.00155	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—MMP2—sarcoma	0.000203	0.00155	CbGpPWpGaD
Pethidine—GRIN2B—Neuronal System—MDM2—sarcoma	0.000198	0.00151	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—MMP2—sarcoma	0.000198	0.00151	CbGpPWpGaD
Pethidine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000193	0.00148	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—CXCR4—sarcoma	0.000193	0.00147	CbGpPWpGaD
Pethidine—GRIN1—BDNF signaling pathway—HRAS—sarcoma	0.000189	0.00144	CbGpPWpGaD
Pethidine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000188	0.00144	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—IL2—sarcoma	0.000186	0.00142	CbGpPWpGaD
Pethidine—GRIN2B—BDNF signaling pathway—HRAS—sarcoma	0.000184	0.00141	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000184	0.0014	CbGpPWpGaD
Pethidine—SLC6A3—Transmission across Chemical Synapses—CREB1—sarcoma	0.000183	0.0014	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—KDR—sarcoma	0.000177	0.00135	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—KDR—sarcoma	0.000173	0.00132	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—JUN—sarcoma	0.000172	0.00131	CbGpPWpGaD
Pethidine—GRIN2C—Neuronal System—HRAS—sarcoma	0.000167	0.00128	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—HRAS—sarcoma	0.000167	0.00127	CbGpPWpGaD
Pethidine—GRIN2A—Transmission across Chemical Synapses—HRAS—sarcoma	0.000167	0.00127	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TEK—sarcoma	0.000166	0.00127	CbGpPWpGaD
Pethidine—GRIN2D—Neuronal System—HRAS—sarcoma	0.000155	0.00119	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—CREB1—sarcoma	0.000155	0.00118	CbGpPWpGaD
Pethidine—ALB—Hemostasis—ANGPT2—sarcoma	0.000152	0.00116	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—CREB1—sarcoma	0.000151	0.00116	CbGpPWpGaD
Pethidine—SLC6A3—Transmission across Chemical Synapses—MDM2—sarcoma	0.000151	0.00115	CbGpPWpGaD
Pethidine—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.00015	0.00115	CbGpPWpGaD
Pethidine—GRIN1—Transmission across Chemical Synapses—HRAS—sarcoma	0.000145	0.00111	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—MMP2—sarcoma	0.000145	0.0011	CbGpPWpGaD
Pethidine—GRIN2B—Transmission across Chemical Synapses—HRAS—sarcoma	0.000142	0.00108	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—MMP2—sarcoma	0.000141	0.00108	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—SRC—sarcoma	0.00014	0.00107	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—CREB1—sarcoma	0.00014	0.00107	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—SRC—sarcoma	0.000137	0.00104	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—VEGFA—sarcoma	0.000137	0.00104	CbGpPWpGaD
Pethidine—ALB—Platelet degranulation—VEGFA—sarcoma	0.000136	0.00104	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—NRAS—sarcoma	0.000135	0.00103	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—VEGFA—sarcoma	0.000133	0.00102	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—NRAS—sarcoma	0.000132	0.001	CbGpPWpGaD
Pethidine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	0.000129	0.000986	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—CXCR4—sarcoma	0.000129	0.000982	CbGpPWpGaD
Pethidine—GRIN2A—Neuronal System—HRAS—sarcoma	0.000128	0.000974	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—EGFR—sarcoma	0.000123	0.000939	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VEGFC—sarcoma	0.000122	0.000932	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—EGFR—sarcoma	0.00012	0.000915	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—TP53—sarcoma	0.00012	0.000912	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CXCR4—sarcoma	0.000117	0.000892	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—KRAS—sarcoma	0.000116	0.000887	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—MDM2—sarcoma	0.000116	0.000885	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—TP53—sarcoma	0.000114	0.000866	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—KRAS—sarcoma	0.000113	0.000865	CbGpPWpGaD
Pethidine—GRIN1—Neuronal System—HRAS—sarcoma	0.000111	0.00085	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—CTNNB1—sarcoma	0.000111	0.000846	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CXCR4—sarcoma	0.000109	0.00083	CbGpPWpGaD
Pethidine—GRIN2B—Neuronal System—HRAS—sarcoma	0.000109	0.000828	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TLE1—sarcoma	0.000108	0.000827	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—CTNNB1—sarcoma	0.000108	0.000824	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—SRC—sarcoma	0.0001	0.000764	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CXCR4—sarcoma	9.88e-05	0.000754	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—HRAS—sarcoma	9.88e-05	0.000754	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—SRC—sarcoma	9.77e-05	0.000745	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—VEGFA—sarcoma	9.76e-05	0.000744	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—NRAS—sarcoma	9.64e-05	0.000735	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—HRAS—sarcoma	9.63e-05	0.000735	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PLCG1—sarcoma	9.6e-05	0.000732	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—VEGFA—sarcoma	9.51e-05	0.000726	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—NRAS—sarcoma	9.4e-05	0.000717	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TLE1—sarcoma	9.17e-05	0.000699	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VEGFC—sarcoma	9.15e-05	0.000698	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—EGFR—sarcoma	8.78e-05	0.00067	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—EGFR—sarcoma	8.56e-05	0.000653	CbGpPWpGaD
Pethidine—SLC6A3—Transmission across Chemical Synapses—HRAS—sarcoma	8.3e-05	0.000634	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—KRAS—sarcoma	8.3e-05	0.000633	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—KRAS—sarcoma	8.09e-05	0.000617	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VEGFC—sarcoma	7.73e-05	0.00059	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—FLT1—sarcoma	7.31e-05	0.000558	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PLCG1—sarcoma	7.19e-05	0.000548	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—IL2—sarcoma	7.08e-05	0.00054	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—HRAS—sarcoma	7.05e-05	0.000538	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CXCR4—sarcoma	6.91e-05	0.000527	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—HRAS—sarcoma	6.87e-05	0.000524	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ATF1—sarcoma	6.83e-05	0.000521	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—HRAS—sarcoma	6.36e-05	0.000485	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CREB1—sarcoma	6.26e-05	0.000478	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—FLT1—sarcoma	6.18e-05	0.000472	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—SRC—sarcoma	6.18e-05	0.000471	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PLCG1—sarcoma	6.08e-05	0.000464	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—VEGFA—sarcoma	6.02e-05	0.000459	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CXCR4—sarcoma	5.84e-05	0.000445	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ATF1—sarcoma	5.77e-05	0.00044	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ENO2—sarcoma	5.45e-05	0.000416	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—HBA1—sarcoma	5.41e-05	0.000413	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IGF1R—sarcoma	5.36e-05	0.000409	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CREB1—sarcoma	5.29e-05	0.000404	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—FOXO1—sarcoma	5.1e-05	0.000389	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—IL2—sarcoma	5.1e-05	0.000389	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PDGFRB—sarcoma	5.09e-05	0.000388	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PDGFRA—sarcoma	5.01e-05	0.000382	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL2—sarcoma	4.63e-05	0.000353	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PLCG1—sarcoma	4.62e-05	0.000353	CbGpPWpGaD
Pethidine—ALB—Metabolism—ENO2—sarcoma	4.59e-05	0.00035	CbGpPWpGaD
Pethidine—ALB—Metabolism—HBA1—sarcoma	4.56e-05	0.000348	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IGF1R—sarcoma	4.53e-05	0.000346	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—FOXO1—sarcoma	4.31e-05	0.000329	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—IL2—sarcoma	4.31e-05	0.000329	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PDGFRB—sarcoma	4.3e-05	0.000328	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PDGFRA—sarcoma	4.24e-05	0.000323	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KDR—sarcoma	4.22e-05	0.000322	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ENO2—sarcoma	4.12e-05	0.000314	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—HBA1—sarcoma	4.09e-05	0.000312	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL2—sarcoma	3.91e-05	0.000299	CbGpPWpGaD
Pethidine—ALB—Metabolism—PLCG1—sarcoma	3.89e-05	0.000297	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KIT—sarcoma	3.89e-05	0.000297	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—NRAS—sarcoma	3.89e-05	0.000297	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ENO2—sarcoma	3.79e-05	0.000289	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—HBA1—sarcoma	3.76e-05	0.000287	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CREB1—sarcoma	3.7e-05	0.000282	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IL2—sarcoma	3.65e-05	0.000279	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KDR—sarcoma	3.57e-05	0.000272	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—EGFR—sarcoma	3.54e-05	0.00027	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PLCG1—sarcoma	3.49e-05	0.000266	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—KRAS—sarcoma	3.35e-05	0.000255	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KIT—sarcoma	3.29e-05	0.000251	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—NRAS—sarcoma	3.29e-05	0.000251	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PLCG1—sarcoma	3.21e-05	0.000245	CbGpPWpGaD
Pethidine—ALB—Hemostasis—SRC—sarcoma	3.19e-05	0.000243	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CREB1—sarcoma	3.13e-05	0.000239	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VEGFA—sarcoma	3.1e-05	0.000237	CbGpPWpGaD
Pethidine—ALB—Hemostasis—NRAS—sarcoma	3.06e-05	0.000234	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MDM2—sarcoma	3.06e-05	0.000234	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—EGFR—sarcoma	2.99e-05	0.000228	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HRAS—sarcoma	2.84e-05	0.000217	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—KRAS—sarcoma	2.83e-05	0.000216	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL2—sarcoma	2.74e-05	0.000209	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCND1—sarcoma	2.67e-05	0.000203	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—JUN—sarcoma	2.66e-05	0.000203	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CTNNB1—sarcoma	2.64e-05	0.000201	CbGpPWpGaD
Pethidine—ALB—Hemostasis—KRAS—sarcoma	2.64e-05	0.000201	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MDM2—sarcoma	2.59e-05	0.000197	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ENO2—sarcoma	2.48e-05	0.000189	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HBA1—sarcoma	2.46e-05	0.000188	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HRAS—sarcoma	2.4e-05	0.000183	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SRC—sarcoma	2.39e-05	0.000182	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TP53—sarcoma	2.34e-05	0.000179	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VEGFA—sarcoma	2.32e-05	0.000177	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL2—sarcoma	2.31e-05	0.000176	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NRAS—sarcoma	2.3e-05	0.000175	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCND1—sarcoma	2.25e-05	0.000172	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—JUN—sarcoma	2.25e-05	0.000172	CbGpPWpGaD
Pethidine—ALB—Hemostasis—HRAS—sarcoma	2.24e-05	0.000171	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CTNNB1—sarcoma	2.23e-05	0.00017	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MYC—sarcoma	2.14e-05	0.000163	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PLCG1—sarcoma	2.1e-05	0.00016	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EGFR—sarcoma	2.09e-05	0.00016	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SRC—sarcoma	2.02e-05	0.000154	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KRAS—sarcoma	1.98e-05	0.000151	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VEGFA—sarcoma	1.96e-05	0.00015	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NRAS—sarcoma	1.94e-05	0.000148	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MYC—sarcoma	1.81e-05	0.000138	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EGFR—sarcoma	1.77e-05	0.000135	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TP53—sarcoma	1.76e-05	0.000134	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HRAS—sarcoma	1.68e-05	0.000128	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KRAS—sarcoma	1.67e-05	0.000127	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TP53—sarcoma	1.48e-05	0.000113	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HRAS—sarcoma	1.42e-05	0.000108	CbGpPWpGaD
